BioBridges

biobridges.com

Are you a clinical development professional who recognizes career advancement by the ability to achieve satisfaction and growth through a focus on the work about which you are inspired? Are you a client who has programs that require additional support and could benefit from having access to a community of experienced professionals who can apply and share their functional expertise?

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

U.S. FDA ACCEPTS BIOHAVEN'S SUPPLEMENTAL NEW DRUG APPLICATION (SNDA) OF NURTEC™ ODT FOR THE PREVENTIVE TREATMENT OF MIGRAINE

Biohaven Pharmaceutical Holding Company Ltd. | October 14, 2020

news image

Biohaven Pharmaceutical Holding Company Ltd. today announced that the U.S. Food and Drug Administration (FDA) has filed and accepted for review its recently submitted supplemental New Drug Application (sNDA) for NURTEC™ ODT (rimegepant) for the preventive treatment of migraine. The Prescription Drug User Fee Act (PDUFA) goal date for completion of the FDA review of the preventive sNDA is set for 2Q2021. Vlad Coric, M.D., Chief Executive Officer of Biohaven commented, "Patients with mi...

Read More

Pharma Tech

AIDOC AND SUBTLE MEDICAL PARTNER TO BRING END-TO-END AI SOLUTIONS TO MEDICAL IMAGING

Aidoc | September 15, 2021

news image

Aidoc, leading provider of AI for medical imaging, announced today a partnership with Subtle Medical, developer of leading AI-based image enhancement bringing best-of-breed AI to both image acquisition and post-acquisition clinical workflows. Aidoc has developed the industry's most robust AI platform, delivering a unified and seamless cross-specialty AI experience for physicians in over 500 medical centers, including the largest clinical deployment of AI in healthcare at Radiology Partners.<...

Read More

Business Insights

SEPTERNA STRENGTHENS LEADERSHIP TEAM TO ADVANCE NOVEL SMALL MOLECULE GPCR MEDICINES

Septerna | July 29, 2022

news image

Septerna, a biotechnology company discovering and advancing novel small molecule medicines targeting G protein-coupled receptors announced the addition of Liz Bhatt, MS, MBA, as Chief Operating Officer, and Ran Xiao as Vice President of Finance and Business Operations to its leadership team. Septerna launched in January 2022 and is growing a pipeline of differentiated products using its GPCR Native Complex™ platform to unlock the vast untapped potential of GPCR drug targets for a wide rang...

Read More

Business Insights

CHARLES RIVER AND VALO HEALTH ANNOUNCE STRATEGIC PARTNERSHIP TO PROVIDE CLIENTS WITH ACCESS TO AI-ENABLED DRUG DISCOVERY SOLUTIONS

Charles River Laboratories International, Inc. and Valo Health, LLC, | January 20, 2022

news image

Charles River Laboratories International, Inc. and Valo Health, LLC, the technology company using human-centric data and computation powered by artificial intelligence (AI) to transform the drug discovery and development process, today announced the formation of a multiyear strategic partnership. This agreement will combine Valo’s Opal Computational Platform with Charles River’s drug discovery and development capabilities to offer a new transformative, AI-enabled drug discovery and d...

Read More
news image

U.S. FDA ACCEPTS BIOHAVEN'S SUPPLEMENTAL NEW DRUG APPLICATION (SNDA) OF NURTEC™ ODT FOR THE PREVENTIVE TREATMENT OF MIGRAINE

Biohaven Pharmaceutical Holding Company Ltd. | October 14, 2020

Biohaven Pharmaceutical Holding Company Ltd. today announced that the U.S. Food and Drug Administration (FDA) has filed and accepted for review its recently submitted supplemental New Drug Application (sNDA) for NURTEC™ ODT (rimegepant) for the preventive treatment of migraine. The Prescription Drug User Fee Act (PDUFA) goal date for completion of the FDA review of the preventive sNDA is set for 2Q2021. Vlad Coric, M.D., Chief Executive Officer of Biohaven commented, "Patients with mi...

Read More
news image

Pharma Tech

AIDOC AND SUBTLE MEDICAL PARTNER TO BRING END-TO-END AI SOLUTIONS TO MEDICAL IMAGING

Aidoc | September 15, 2021

Aidoc, leading provider of AI for medical imaging, announced today a partnership with Subtle Medical, developer of leading AI-based image enhancement bringing best-of-breed AI to both image acquisition and post-acquisition clinical workflows. Aidoc has developed the industry's most robust AI platform, delivering a unified and seamless cross-specialty AI experience for physicians in over 500 medical centers, including the largest clinical deployment of AI in healthcare at Radiology Partners.<...

Read More
news image

Business Insights

SEPTERNA STRENGTHENS LEADERSHIP TEAM TO ADVANCE NOVEL SMALL MOLECULE GPCR MEDICINES

Septerna | July 29, 2022

Septerna, a biotechnology company discovering and advancing novel small molecule medicines targeting G protein-coupled receptors announced the addition of Liz Bhatt, MS, MBA, as Chief Operating Officer, and Ran Xiao as Vice President of Finance and Business Operations to its leadership team. Septerna launched in January 2022 and is growing a pipeline of differentiated products using its GPCR Native Complex™ platform to unlock the vast untapped potential of GPCR drug targets for a wide rang...

Read More
news image

Business Insights

CHARLES RIVER AND VALO HEALTH ANNOUNCE STRATEGIC PARTNERSHIP TO PROVIDE CLIENTS WITH ACCESS TO AI-ENABLED DRUG DISCOVERY SOLUTIONS

Charles River Laboratories International, Inc. and Valo Health, LLC, | January 20, 2022

Charles River Laboratories International, Inc. and Valo Health, LLC, the technology company using human-centric data and computation powered by artificial intelligence (AI) to transform the drug discovery and development process, today announced the formation of a multiyear strategic partnership. This agreement will combine Valo’s Opal Computational Platform with Charles River’s drug discovery and development capabilities to offer a new transformative, AI-enabled drug discovery and d...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us